207 related articles for article (PubMed ID: 15723968)
1. Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats.
Dahly-Vernon AJ; Sharma M; McCarthy ET; Savin VJ; Ledbetter SR; Roman RJ
Hypertension; 2005 Apr; 45(4):643-8. PubMed ID: 15723968
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier.
McCarthy ET; Sharma R; Sharma M
Kidney Int; 2005 Jan; 67(1):152-6. PubMed ID: 15610238
[TBL] [Abstract][Full Text] [Related]
3. Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury.
Williams JM; Sarkis A; Hoagland KM; Fredrich K; Ryan RP; Moreno C; Lopez B; Lazar J; Fenoy FJ; Sharma M; Garrett MR; Jacob HJ; Roman RJ
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1764-77. PubMed ID: 18842817
[TBL] [Abstract][Full Text] [Related]
4. GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury?
Gnudi L; Viberti G; Raij L; Rodriguez V; Burt D; Cortes P; Hartley B; Thomas S; Maestrini S; Gruden G
Hypertension; 2003 Jul; 42(1):19-24. PubMed ID: 12771048
[TBL] [Abstract][Full Text] [Related]
5. The interrelationship between TGF-beta1 and nitric oxide is altered in salt-sensitive hypertension.
Ying WZ; Sanders PW
Am J Physiol Renal Physiol; 2003 Nov; 285(5):F902-8. PubMed ID: 12865256
[TBL] [Abstract][Full Text] [Related]
6. Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.
Luo P; Zhou Y; Chang HH; Zhang J; Seki T; Wang CY; Inscho EW; Wang MH
Am J Physiol Renal Physiol; 2009 Mar; 296(3):F556-63. PubMed ID: 19129258
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats.
Dahly AJ; Hoagland KM; Flasch AK; Jha S; Ledbetter SR; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2002 Sep; 283(3):R757-67. PubMed ID: 12185011
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats.
Otsuka F; Yamauchi T; Kataoka H; Mimura Y; Ogura T; Makino H
Am J Physiol; 1998 Jun; 274(6):R1797-806. PubMed ID: 9841488
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.
Williams JM; Sharma M; Anjaiahh S; Falck JR; Roman RJ
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F501-5. PubMed ID: 17507602
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 in hypertensive renal injury in Dahl salt-sensitive rats.
Tamaki K; Okuda S; Nakayama M; Yanagida T; Fujishima M
J Am Soc Nephrol; 1996 Dec; 7(12):2578-89. PubMed ID: 8989736
[TBL] [Abstract][Full Text] [Related]
11. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
Tahira Y; Fukuda N; Endo M; Ueno T; Matsuda H; Saito S; Matsumoto K; Mugishima H
J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals.
Sharma R; Khanna A; Sharma M; Savin VJ
Kidney Int; 2000 Jul; 58(1):131-6. PubMed ID: 10886557
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
14. Chronic activation of glomerular mitogen-activated protein kinases in Dahl salt-sensitive rats.
Hamaguchi A; Kim S; Izumi Y; Iwao H
J Am Soc Nephrol; 2000 Jan; 11(1):39-46. PubMed ID: 10616838
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension.
Feng W; Chumley P; Prieto MC; Miyada K; Seth DM; Fatima H; Hua P; Rezonzew G; Sanders PW; Jaimes EA
Hypertension; 2015 Apr; 65(4):813-20. PubMed ID: 25624342
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.
Chen CC; Geurts AM; Jacob HJ; Fan F; Roman RJ
Physiol Genomics; 2013 Feb; 45(3):110-8. PubMed ID: 23249995
[TBL] [Abstract][Full Text] [Related]
17. Relaxin ameliorates salt-sensitive hypertension and renal fibrosis.
Yoshida T; Kumagai H; Suzuki A; Kobayashi N; Ohkawa S; Odamaki M; Kohsaka T; Yamamoto T; Ikegaya N
Nephrol Dial Transplant; 2012 Jun; 27(6):2190-7. PubMed ID: 22086971
[TBL] [Abstract][Full Text] [Related]
18. Effects of lipid-lowering agents in the Dahl salt-sensitive rat.
Wilson TW; Alonso-Galicia M; Roman RJ
Hypertension; 1998 Jan; 31(1 Pt 2):225-31. PubMed ID: 9453307
[TBL] [Abstract][Full Text] [Related]
19. Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats.
Roman RJ; Alonso-Galicia M; Wilson TW
Am J Hypertens; 1997 May; 10(5 Pt 2):63S-67S. PubMed ID: 9160783
[TBL] [Abstract][Full Text] [Related]
20. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
Zhang JJ; Bledsoe G; Kato K; Chao L; Chao J
Kidney Int; 2004 Aug; 66(2):722-32. PubMed ID: 15253727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
